Posted inGenetics
KPMG 2025 Life Sciences CEO Outlook
KPMG recently released its 2025 U.S. CEO Outlook. A critical section of the survey, which took place in September, explored…
Posted inBiotechnology
Fertility Preservation Challenges in Endometrioid Cancer Cases
In the realm of reproductive health, the implications and challenges of cancer treatments on fertility are profound and complex. A…
Posted inBiotechnology
Allostatic Load Links to Kidney Cancer Risk
In a groundbreaking exploration of the biological interplay between chronic stress and cancer, a new study published in BMC Cancer…
Posted inResearch
Former FDA leader to chair Charles River advisory board on animal testing alternatives
As excitement around animal testing alternatives reaches a fever pitch, Charles River Laboratories is making a move to strengthen its…
Posted inBiotechnology
Aicuris antiviral scores in phase 3 HSV trial, setting up FDA filing
In the mid-1990s, researchers identified the viral helicase–primase enzyme complex as a target for a potential anti-herpes simplex virus (HSV)…
Posted inBiotechnology
Pelage Pharma raises $120M series B to untangle roots of hair loss with regenerative med
The latest strand in Pelage Pharmaceuticals’ growing funds comes from a $120 million series B fundraising round that the biotech…
Posted inBiotechnology
Sex-Specific Therapeutics Identified in Lung Cancer Study
In an extraordinary breakthrough in the realm of cancer research, a recent study has unraveled the intricate multi-omics protein signaling…
Posted inBiotechnology
MRI Reveals Regional Drivers of Human CSF Flow
In a groundbreaking study that promises to reshape our understanding of neural physiology, researchers have unveiled new insights into the…
Posted inBiotechnology
Optimizing tRNA Synthetase Pairs for Noncanonical Amino Acids
In recent years, the burgeoning field of synthetic biology has ushered in remarkable innovations, particularly in the realms of genetic…
Posted inMedical Technology
Boehringer, Click’s digital therapeutic meets phase 3 goal in schizophrenia
German drugmaker Boehringer Ingelheim and Click Therapeutics said their phase 3 trial of a prescription digital therapeutic for the negative…